TechMARK movers: Autonomy remains investor favourite

1st Feb 2011 13:08

Search software provider Autonomy Corporation is higher even though it reported a fall in fourth quarter profit. Profit in the three months to December 2010 came in at $88.4m, down from $95.8m last time, on revenues of $244.5m up from $223m. Broker Peel Hunt is cautious about Autonomy's future. It points to a slowdown in the second half of 2010 and believes there is a risk that 2011 forecasts may have to be downgraded. Peel Hunt has set a target price of 1,400p. Oxford Biomedica has fallen back following yesterday's announcement that it was paying £1.9m for a manufacturing facility in Oxford. The facility is owned by Recipharm, which acquired the site when it bought the former AIM-quoted gene and proteins supplier Cobra Bio-Manufacturing one year ago. Cobra ran out of cash. Oxford Biomedica expects to get the facility up and running again by 2012. FTSE TechMARK - Risers Autonomy Corporation (AU.) 1,595.00p +6.62%Spectris (SXS) 1,424.00p +5.48%ARM Holdings (ARM) 531.50p +3.00%Optos (OPTS) 197.75p +2.20%Wolfson Microelectronics (WLF) 307.50p +1.82%Innovation Group (TIG) 16.25p +1.56%Antisoma (ASM) 2.25p +1.35%Asterand (ATD) 20.25p +1.25%Emblaze Ltd. (BLZ) 44.00p +1.15%Kofax (KFX) 343.00p +0.73%FTSE TechMARK - Fallers Oxford Biomedica (OXB) 5.45p -6.03%Vernalis (VER) 48.00p -4.00%Promethean World (PRW) 56.25p -3.85%DRS Data & Research Services (DRS) 21.50p -3.37%Vectura Group (VEC) 79.75p -2.45%BAE Systems (BA.) 333.80p -2.40%QinetiQ Group (QQ.) 129.60p -2.26%E2V Technologies (E2V) 108.50p -1.81%Sinclair Pharma (SPH) 38.00p -1.30%Psion (PON) 90.50p -1.09%